Finance

Lists
19KA:FRA
CorMedix Inc
€6.66
+1.96%
(+0.13) 1D
Sep 17, 10:00:00 PM GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for 19KA...
Open
€6.66
High
€6.66
Low
€6.66
Mkt. cap
607.19M
Avg. vol.
5.00
Volume
0.00
52-wk high
€11.80
52-wk low
€5.20
No. of employees
191
Open
€6.66
High
€6.66
Low
€6.66
Mkt. cap
607.19M
Avg. vol.
5.00
Volume
0.00
52-wk high
€11.80
52-wk low
€5.20
No. of employees
191
About CorMedix Inc
CEO-
Employees191
Founded2006
HeadquartersBerkeley Heights, New Jersey, United States
SectorPharmaceutical industry
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
104.28M
128.62M
127.43M
101.93M
Cost of goods sold
7.57M
11.17M
12.00M
14.50M
Cost of revenue
7.57M
11.17M
12.00M
14.50M
Research and development expenses
5.10M
8.60M
7.21M
6.68M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
36.64M
29.38M
34.25M
27.53M
Operating expense
45.36M
48.12M
51.76M
44.52M
Total operating expenses
52.93M
59.29M
63.77M
59.02M
Operating income
51.35M
69.33M
63.66M
42.91M
Other non operating income
-
-
-268.00K
-71.00K
EBT including unusual items
52.58M
56.45M
55.64M
38.73M
EBT excluding unusual items
51.89M
68.47M
63.39M
42.84M
Income tax expense
-55.99M
42.43M
17.04M
12.74M
Effective tax rate
-106.49%
75.16%
30.63%
32.90%
Other operating expenses
-
-
-
-
Net income
108.56M
14.02M
38.60M
25.99M
Net profit margin
104.11%
10.90%
30.29%
25.50%
Earnings per share
1.41
0.16
0.35
-
Interest and investment income
1.56M
889.98K
-
-
Interest expense
-948.24K
-1.82M
-
-
Net interest expenses
612.03K
-927.10K
-
-
Depreciation and amortization charges
-
-
-
-
EBITDA
55.14M
79.76M
74.20M
53.45M
Gain or loss from assets sale
-
-86.00K
-
-
AI content may include mistakes. Learn more
Google apps